Advanced Search
Contact | Corporate | Help

Daily news email for August 26, 2010 | Click here for updated news

SourceSolution News
New reporting features added to the Supplier Relationship Management system. Sign up here for our daily webinar to learn more.

Search over 86,000 clinical trials by phase of development and indication at www.sourcesolution.com

PlanIt client portal software lets you exchange and track documents, manage budgets and assign tasks. 3 day implementation!

 BioSpace
Alexza Pharmaceuticals, Inc.'s Staccato Nicotine Licensed to Cypress Bioscience Inc.; Will Pay An Upfront Payment Of $5 Million

Vitamin D Status Predicts HF Outcome, University Medical Center Study

Cold Viruses Could Be Cancer Fighters, Salk Institute for Biological Studies Reveals

Genzyme Corporation To End Rationing Of Cerezyme In September; U.S. Patients Can Resume Normal Dosing

Chelsea Therapeutics, Inc. Gets FDA Nod For Arthritis Trial

BioSpace - Breaking News
Enzo Biochem Clinical Labs, Inc. Takes Major Step in Becoming National Provider of Predictive Diagnostics

Swedish Orphan Biovitrum AB's Kineret(R) has Received Orphan Drug Designation in the USA

FDA Accepts Sanofi Pasteur's Application to Expand Indication of Menactra(R) Vaccine to Infants and Toddlers

AREVA Med LLC Forms High Level Science Advisory Committee

LFB S.A.'s Recombinant Anti-CD20 Monoclonal Antibody is Granted Orphan Drug Status in the USA for Chronic Lymphocytic Leukemia

Biotech News - Business Wire
International Stem Cell Institute Launches Major Adipose Adult Stem Cell Therapy ProgramThe New Frontier of Medicine is Your Fat

Resumen: TomTec presenta en el congreso de la European Society of Cardiology en Estocolmo "4D MV-Assessment", la nueva solución 3D para un diagnóstico médico mejorado en el tratamiento de la válvula mitral

Samenvatting: TomTec introduceert 4D MV-Assessment, de nieuwe 3D-toepassing voor betere diagnoses bij mitraalkleppen tijdens het ESC (European Society of Cardiology) congres in Stockholm

Health Discovery Corporation 2010 Shareholder Letter

TomTec présente 4D MV-Assessment, la nouvelle solution 3D qui améliore la fiabilité du diagnostic lors des interventions thérapeutiques au niveau de la valvule mitrale, lors du congrès de la Société européenne de cardiologie à Stockholm

 Biotech News - PR Newswire
Frankfurt am Main Emergency Medical Services Makes Masimo Rad-57 Pulse CO-Oximeters Mandatory for All Vehicles

CareFusion Announces National Launch of Spinal Fracture Device

Lotus Pharmaceuticals Enter R-Bambuterol(R) Clinical Trial I

SciQuest Makes the Inc. 500|5000 List of Fastest-Growing Companies for Fourth Consecutive Year

China-Biotics Ranked Number 62 on FORTUNE'S 100 Fastest-Growing Companies' List

 Biotechnology - Moreover
Titan Pharmaceuticals has the Highest Beta in the Biotechnology Industry (TTNP, VNDA, HGSI, CTIC, ACAD)

This Comprehensive Global Biotechnology Industry Profile Is an Essential Resource for Top-Level Data and Analysis

GTG settles dispute with two US biotech cos

IFR Researchers have Demonstrated a Potential New Way of Preventing Spoilage in Cheese

Resveratrol Oligomers from Vatica albiramis
Burrill Report
Researchers Find Key Proteins for Drought Tolerance

Judge Blocks Funding for Stem Cell Research

Deals on a Roll

Aspen Unburdens Sigma with Pharmaceutical Division Buy

Life Technologies To Buy Ion Torrent for $375 Million

 CenterWatch - Clinical Trials
Synexus sees clinical trials rise 25% in Hungary

Merck partners with Alectos to develop new type of Alzheimer's treatment

Medco Health Solutions to acquire United BioSource in $730 million all-cash deal

ClinTec partners with Elephant Capital for Asia Pacific expansion

ActivMed opens N.H. research center

 Clinical Trials - Business Wire
Pico-Tesla Expands Operations to Midwest Region

AUXILIO Provides Business Update and Outlook

ArtVentive Medical Group, Inc. and Medical Murray Inc. Sign Agreement

InSite Vision Commences Phase 1/2 Clinical Study of ISV-303 for Post-Surgical Ocular Pain and Swelling

Melanoma Research Alliance Announces $5.2 Million in New Grants to Support Six Innovative Multidisciplinary Research Programs
Clinical Trials - PR Newswire
Shire Announces European Approval of VPRIV(R) (velaglucerase alfa) for the Treatment of Type 1 Gaucher Disease

BrainScope(TM) Announces Findings of Traumatic Brain Injury Study in the Emergency Department

Salinas Valley Memorial Completes Successful Implant of Cardiac Monitor and Alert System

Heart Transplant Patients With Common Disorder Have High Survival Rates

OrthoAccel Technologies, Inc. Announces Definitive Distribution Agreements in Two Key Markets

 Contract Pharma
Catalent To Provide Materials for AML Trial

Novartis Completes Alcon Option

CMC Biologics Adds Single-Use Facility

Sartorius Stedim, SAFC Enter Bio-Service Alliance

CMC Biologics Adds Single-Use Facility


 FDA Drugs- What's New
FDA Drug Safety Communication: Ongoing Safety Review of Stalevo and possible increased cardiovascular risk

FDA Drug Safety Communication: Aseptic meningitis associated with use of Lamictal (lamotrigine)

FDA Drug Safety Communication: Serious medication errors from intravenous administration of nimodipine oral capsules

FDA Drug Safety Communication: Ongoing safety review of Evamist (estradiol transdermal spray) and unintended exposure of children and pets to topical estrogen

FDA Drug Safety Communication: Eosinophilic pneumonia associated with the use of Cubicin (daptomycin)
FDA News - Business Wire
Amneal Announces FDA Approval for Spironolactone HCl Tablets

Resumen: La FDA concede la designación de huérfano al anticuerpo monoclonal recombinante anti-CD20 de LFB para la leucemia linfocítica crónica

Samenvatting: Recombinant anti-CD20 monoklonaal antilichaam van LFB ontvangt status weesgeneesmiddel in de VS voor de behandeling van chronische lymfoïde leukemie

NeoPharm, Inc. Announces Second Quarter 2010 Financial Results

Der rekombinante monoklonale Antikörper anti-CD20 erhält den Orphan-Drug-Status in den USA zur Behandlung der chronischen lymphatischen Leukämie

 FDA Press Releases
FDA Warns Consumers to Avoid TimeOut Capsules

FDA releases guidance on federal menu labeling requirements

FDA Warns of Possible Dangers from Portable Foot-Tanning Device

Study: Presence of murine leukemia virus found in CFS Patients, others

Urgent Nationwide Frozen Mamey Fruit Products Recall

 FDA Vaccines, Blood and Biologics - What's New
URGENT - Voluntary Market Withdrawal of Octagam [Immune Globulin Intravenous (human)] 5% Liquid Preparation

July 19, 2010 Approval Letter - Fluarix

Recall of Panoscreen lll

AFLURIA

FluMist
FierceBiotech
Under fire, Cypress pledges $33M to acquire CNS programs

Antigenics shares spike as GSK launches PhIII

Leaks highlight Sanofi's strategy on Genzyme deal

Roche melanoma drug registers striking results

Inspire scuttles eye drug and pencils new deal with Allergan

 FierceBiotech IT
Cloud to host Saffron predictive analytics tool

UK study supports dose-response modeling

Google-like code aids drug development

Top 10 list rejects cloud for clinical data

NIH funds software-based brain plasticity trials

 FierceBiotech Research
Mouse virus linked to chronic fatigue syndrome

Mouse virus found in chronic fatigue cases

Judge's ruling throws ESC research work into disarray

Tougher disclosure rules spur flak from biomedical researchers

AVI approach saves monkeys with Ebola
FiercePharma
Design's the thing for consumer-friendly drugs

Celgene talks Revlimid defense strategy

Cephalon CEO checks out on medical leave

Price-bound Sanofi may forego Genzyme bid

Alcon in hand, Novartis zeroes in on minority stake

 FiercePharma Manufacturing
FDA moves a step closer to executive prosecutions

Lilly, Pfizer announce manufacturing cuts

Robotic IV compounding comes to UMass

Hyaluron contamination response earns FDA warning

Texas kicks in for vegan vaccine funding

 FierceVaccines
Bill Gates on vaccines: "Our investment is mind-blowing"

Will FDA reconsider hen vaccination program

Antigenics shares gain on GSK's ambitious PhIII vax program

Feds earmark $2B for new, faster vaccine tech

CDC: More teens getting their recommended shots
Health News - BizJournals.com
Marina Biotech sells autism-treatment asset in deal worth up to $27M

Ebinger named president of Aurora's Grafton hospital

Primary Care adds 2nd site in Kenmore

University of Texas health IT program granted $2.7M

State settles with Stryker Biotech

 Health News - CNBC
Health Net Inc. Director Thomas Farley dies

Stocks to Watch: Airgas, Medtronic and More ...

Alexza Pharma licenses smoking cessation product

Mass. reaches $1.35M settlement with biotech co.

J&J Unit Recalls Hip Replacement Systems

 Health News - Fox Business
Genzyme: US Cerezyme Patients Return To Normal Dosing In Sept

Exelixis Gains; Drug Indexes Split In Early Trade

Johnson & Johnson Unit Recalls ASR Hip-Replacement Device

Novartis To Invest $500 Million To Build Factory In Brazil -Report

Novartis Seals Alcon Deal, Closer To Full Control
Marketwire - Pharma and Biotech
John Figueroa, President of McKesson U.S. Pharmaceutical, Is Named Executive of the Decade by GSCLG

Radient Pharmaceuticals Provides Domestic and International Target Market Details for Its Onko-Sure(R) IVD Cancer Diagnostic Test

Vicor Technologies Announces Abstracts of PD2i(R) Studies Accepted for Presentation at Poster Session of 2010 Heart-Brain Summit

SOHM Reports Consecutive Record Quarters With 1,000 Percent Year-Over-Year Revenue Increase for the Second Quarter 2010

Cypress Bioscience Licenses Alexza Pharmaceutical's Staccato(R) Nicotine

 MassBio News
Massachusetts maintains national strength in biotech despite downturn

MassBio Statement on Stem Cell Decision

Sixteen MassBio Member Companies Selected to Present at BioPharm America 2010 and the MassBio Investors Forum

Check out the MassBio Innovation Exchange!

Nuclea Biotechnologies opens new Genomic Center in Pittsfield

 Medical Pharma - PR Newswire
HIV and Other Tests Will Be Offered at Free Health Clinic for Uninsured Gulf Coast Residents

Deloitte Issue Brief: Mobile Personal Health Records May Offer Consumers Key to Technology-Enabled Self-Care

DFW Employers Kick Off Project to Improve Health of Area Employees and Their Families

As a Result of Health Reform, California Provider Groups Focusing on Accountable Care Organizations to Better Coordinate Care

DePuy Orthopaedics Voluntarily Recalls ASR Hip System
National Center for Biotechnology Information
BLAST NEWS

BLASTFeed

Blast Tips

dbGaP News and Announcements

NCBI News

 Nature Biotechnology
Waking up and smelling the coffee

Reply to Waking up and smelling the coffee

Genetic stability in two commercialized transgenic lines (MON810)

Distances needed to limit cross-fertilization between GM and conventional maize in Europe

Case study: India's billion dollar biotech

 New York Times- Biotechnology
Genetics Pushes Canola Into the Wild

Europe Clears Import of New Biotech Corn Varieties

Exploring Algae as Fuel

Europeans Seek to Ease Wide Ban on Biotech Crops

Europe’s New Approach to Biotech Food
New York Times- Pharmaceuticals
Lilly Stops Alzheimer's Drug Trials

AARPSays Brand-Name Drug Prices Up 8% in 2009

AARP Says Brand-Name Drug Prices Up 8% in 2009

What to Tell Alzheimer’s Patients After a Trial Goes Awry

A Problem Easily Fixed

 OnBioVC
Gemin X Pharmaceuticals, Inc.: Series E $8M

Great Lakes Pharmaceuticals, Inc.: Series B $3.1M

Health Market Science, Inc.: Series B $6.1M

Solazyme, Inc.: Series D $52M

CeNeRx BioPharma, Inc.: Series C $10M

 Outsourcing-Pharma
Almac Diagnostics discusses new biomarker service

Asia Pacific trial sector poised for continued growth, says Novotech

ERT develops IVR suicidality monitoring for trials

Demand for discovery services recovering, says Domainex

Biomarkers indispensible in cancer drug development, says Quintiles
Pharma News - Business Wire
Achèvement réussi du développement clinique d'Uniplas®

Desarrollo clínico Uniplas® completado satisfactoriamente

CORRECTING AND REPLACING Uniplas® Clinical Development Successfully Completed

Los PharmaTrust MedCentres, calificados como "tecnología revolucionaria" por la CNN

Research and Markets: H. Lundbeck A/S-Detailed Product Pipeline 2010 Contains Extensive Information in Tabular and Graphical Formats

 Pharma News - PharmiWeb
NICE proposes to restrict access to Velcade® (bortezomib) in newly diagnosed multiple myeloma patients

Key Bio Nano Consulting partner develops novel nanolitre scale technique for determining protein stability and ligand-binding affinity

Biotec launches specialist primary packing service

Arrowhead Releases New Report Revealing Prospects for Traumatic Brain Injury Therapy Market

Positive NICE guidance opens the door for thousands of rheumatoid arthritis patients

 Pharma News - PR Newswire
Target to Serve as Prevention HQ this Flu Season

Cardioxyl Pharmaceuticals Initiates Dose-Defining Phase IIa Study of Its Lead Candidate, CXL-1020, in Heart Failure Patients

Aethlon Medical Announces Approval of Hepatitis C Virus (HCV) Treatment Program

Alexza's Staccato® Nicotine Licensed to Cypress Bioscience

Delcath Systems Announces Completion of Common Stock Offering
Pharmaceutical - Moreover
Video: Teva chief operating officer Richard Daniell on the pharmaceutical giants plans

PPD Names New Vice President of Quality Management Systems

Axxess Pharma Inc. Anticipates Additional $700,000 in Annual Sales From Pre-Natal, Non-Constipating

Pharmaceutical Manufacturing has the Power to develop Efficient Medicines

Singapore's July manufacturing output growth slowest in 8 months

 PR Leap - Biotech
Executive Impact Group Provides Startup Solutions to VC funded $40M Calithera Biosciences

Vivante GMP Solutions Announces Expansion of Technical Staff

Vivante GMP Solutions Announces Successful Completion of GMP Manufacture, Lot Release Campaign

SourceSolution Announces the Implementation of the PlanIt Partner Portal for Vivante GMP Solutions

Vivante GMP Solutions Announces Successful Completion of GMP Fill/Finish, Lot Release Campaign for Etubics Corporation

 PRWeb - Biotechnology
Agile Sciences awarded NIH SBIR grant to validate biofilm dispersion...

The Workplace Group® Ranked #3 Mid-Market Provider of Recruitment...

Medyssey Spine Receives FDA 510(k) Clearance for Zenius(TM)...

Quincy Bioscience Receives Investment Capital from DaneVest

Novo Nordisk Creates App to Help Doctors Dose Insulin, Supporting...
PRWeb - Pharmaceuticals
Putting China in Your Business Future ... Just Got Less Expensive

Arrowhead Releases New Report Revealing Prospects for Traumatic Brain...

Envision CEO to Discuss Telepharmacy Practices at 70th FIP World...

Rush Limbaugh Touts Benefits of E-Cigarettes, Slams FDA

Nutricap Labs Named to 2010 Inc. 500 List, Recognized as One of...

 Scientific American
Light Diet: Eating Food without Seeing It May Impede Ability to Judge Hunger

Psychedelic Drugs Show Promise as Antidepressants

Closeted Calamity: The Hidden HIV Epidemic of Men Who Have Sex with Men

How Fast Can Microbes Clean Up the Gulf Oil Spill

Can Exercise Make You Feel More Full

 Xconomy Life Sciences
Finistere Planning New Venture Fund, National Cancer Institute Official Offers SBIR Insights, Ramius Still Tries to Woo Cypress Bio, & More San Diego Life Sciences News

Promising Skin Cancer Drug Could Be First Big Win for Plexxikon's Structure-Based Drug Discovery Approach

Ramius Still Wants Cypress Bio

Finistere Plans New Venture Fund

A SBIR Program Director Offers Insights in Small Business Innovation Research Grantsmanship in the Life Sciences
Yahoo Biotech News
Stem-Cell Ruling Causes Gloom, Anxiety Among Scientists (Time.com)

Gloom and Confusion in the Stem Cell Community (Time.com)

Study links Chinese kidney problems to genes (AFP)

Effect on stem cell ruling on companies unclear (Reuters)

Obama to Appeal Stem Cell Ruling (HealthDay)


SourceSolution © 2008-2012